Apogee Therapeutics
Glenn Whelan is an experienced clinical scientist specializing in respiratory therapeutics. Currently serving as Senior Director at Apogee Therapeutics, Glenn's career includes roles at GSK as both Clinical Development Consultant and Medical Director for Global Medical Affairs in Respiratory Biologics. Previous positions encompass Senior Director of Clinical Development at Aiolos Bio and significant contributions at AstraZeneca as Senior Medical Science Liaison and Global Medical Affairs Lead. Glenn has a solid foundation in clinical trial design and program development, with earlier roles at Genentech and CSL Behring focused on respiratory and immunology fields. Academic experience includes serving as Clinical Faculty and Assistant Professor at the University of South Florida. Glenn holds a Pharm.D. from the University of Florida and an AA from the University of North Florida.
This person is not in any teams
This person is not in any offices
Apogee Therapeutics
1 followers
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023.